Resilient leadership training services
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40122C00012
- Awardee
-
Zocchi America, Inc. UEI FMKJM1M8WYC7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,997,825
Award facts
- Opportunity
-
- FDARFQ1245922 Solicitation number
- Contract value 100% obligated
- $2,997,825.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 611430 Professional and Management Development Training
- PSC
- U001 Education/Training- Lectures
- Set-aside
- 8(a) Sole Source
- Competition
- Not Available for Competition · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Exercise an Option | $999,275 | |
| Exercise an Option | $999,275 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $999,275 |
About this award
The Food and Drug Administration (FDA) awarded a $2.99 million firm fixed price definitive contract to Zocchi America, Inc. for Resilient Leadership Training Services. The contract, designated as an 8(a) sole source set aside, was awarded on December 13, 2021, with an ultimate completion date of January 1, 2025, and will be performed in Silver Spring, Maryland. Zocchi America, Inc., a management consulting firm specializing in organizational development and federal government services, holds SBA certification as an 8(a) Program Participant through August 13, 2025.
Under this contract, Zocchi America will deliver comprehensive leadership development services to the FDA, including resilience training, leadership coaching, training program development and delivery, and leadership board development support. These services are designed to strengthen personnel development capabilities and enhance governance functions across the agency. The engagement supports the FDA's mission to maintain effective oversight and regulatory capabilities by building the leadership competencies of its workforce. No subcontractors are indicated on this award, with all services to be delivered directly by the prime contractor.
Quick answers
Who was awarded contract 75F40122C00012?
75F40122C00012 was awarded to Zocchi America, Inc. by Food and Drug Administration (Department of Health and Human Services) on December 13, 2021.
How much is contract 75F40122C00012 worth?
The government has obligated $2,997,825 on 75F40122C00012.
Was contract 75F40122C00012 competed?
The extent of competition for 75F40122C00012 was not available for competition. The government received 1 offer. It was set aside: 8(a) Sole Source.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award